NASDAQ: ABVCAbvc Biopharma Inc Stock Ownership - Who owns Abvc Biopharma?
Insider buying vs selling
Have Abvc Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ABVC insiders and whales buy or sell their stock.
ABVC Shareholders
What type of owners hold Abvc Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Tsung Shann Jiang | 76.71% | 12,103,971 | $12.47M | Insider |
| Shuling Jiang | 50.12% | 7,908,805 | $8.15M | Insider |
| Eugene Jiang | 4.64% | 732,716 | $754.70k | Insider |
| Yoshinobu Odaira | 1.04% | 163,702 | $168.61k | Insider |
| Avantax Planning Partners Inc | 0.91% | 143,968 | $148.29k | Institution |
| Geode Capital Management LLC | 0.50% | 79,285 | $81.66k | Institution |
| Shinyu Miao | 0.43% | 67,378 | $69.40k | Insider |
| Vanguard Group Inc | 0.30% | 46,947 | $48.36k | Institution |
| Citadel Advisors LLC | 0.26% | 40,743 | $41.97k | Institution |
| Xtx Topco Ltd | 0.22% | 34,405 | $35.44k | Institution |
ABVC vs Biotech Stocks
Abvc Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.